全文获取类型
收费全文 | 1294篇 |
免费 | 104篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 126篇 |
妇产科学 | 28篇 |
基础医学 | 211篇 |
口腔科学 | 36篇 |
临床医学 | 128篇 |
内科学 | 191篇 |
皮肤病学 | 10篇 |
神经病学 | 176篇 |
特种医学 | 36篇 |
外科学 | 104篇 |
综合类 | 1篇 |
预防医学 | 139篇 |
眼科学 | 17篇 |
药学 | 76篇 |
中国医学 | 1篇 |
肿瘤学 | 105篇 |
出版年
2024年 | 3篇 |
2023年 | 13篇 |
2022年 | 22篇 |
2021年 | 24篇 |
2020年 | 20篇 |
2019年 | 27篇 |
2018年 | 42篇 |
2017年 | 27篇 |
2016年 | 35篇 |
2015年 | 41篇 |
2014年 | 48篇 |
2013年 | 75篇 |
2012年 | 91篇 |
2011年 | 100篇 |
2010年 | 54篇 |
2009年 | 38篇 |
2008年 | 88篇 |
2007年 | 78篇 |
2006年 | 73篇 |
2005年 | 79篇 |
2004年 | 69篇 |
2003年 | 60篇 |
2002年 | 66篇 |
2001年 | 27篇 |
2000年 | 25篇 |
1999年 | 19篇 |
1998年 | 15篇 |
1997年 | 11篇 |
1996年 | 8篇 |
1995年 | 12篇 |
1994年 | 6篇 |
1993年 | 6篇 |
1992年 | 12篇 |
1991年 | 14篇 |
1990年 | 11篇 |
1989年 | 5篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1981年 | 3篇 |
1979年 | 10篇 |
1978年 | 4篇 |
1977年 | 5篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有1399条查询结果,搜索用时 15 毫秒
71.
Jouko Tuomisto Tapio Ranta Pekka Mnnist Ari Saarinen Juhani Leppluoto 《European journal of pharmacology》1975,30(2):221-229
In rats adapted to a +30°C temperature for one week, transfer to a temperature of +4°C increased immunoassayable serum TSH from 150–300 ng/ml 800–2000 ng/ml in 30 min. Since this response, as well as the level of serum TSH without stimulation, were decreased by reserpine, phentolamine, phenoxybenzamine, disulfiram and diethyldithiocarbamate, noradrenaline may be involved in the stimulation of TSH secretion. TRH-induced TSH increase was not blocked by reserpine.
1-Dopa, a noradrenaline precursor, decreased the TSH response to cold; -methyl-p-tyrosine increased the TSH level. Apomorphine decreased the level of serum TSH and inhibited the response to cold. The possibility of a dopaminergic inhibitory factor released from the hypothalamus is discussed. 5-HT has possibly a role in the acetylcholine is involved. 相似文献
72.
Background: The in‐hospital Utstein Guidelines may be used to evaluate resuscitation strategies. This study utilized the Utstein template prospectively to examine changes in outcome and outcome‐related factors after resuscitation outside critical care areas over a 10‐year period. Methods: Seinäjoki Central Hospital (460 beds) is a secondary hospital in Finland with acute care activities. In 1993, the in‐hospital cardiac arrest management was remodelled; an intensive care unit‐based resuscitation team was formed and prospective data collection began (modified according to the Utstein Guidelines in 1997). An analysis of resuscitation attempts outside critical care areas between 1993 and 2002 was performed. To monitor developments, the patients were divided into two groups (first period, 1993–97; second period, 1998–2002). Variables independently associated with survival were identified using multiple logistic regression analysis. Results: During the 10‐year period, resuscitation was attempted in 183 patients. Survival to discharge was 6% during the first period and 16% during the second (P = 0.048). The corresponding figures for survival at 1 year from the event were 3% and 10% (P = 0.064). Independent predictors of survival were ventricular fibrillation or ventricular tachycardia as the initial rhythm [odds ratio (OR), 9.8; confidence interval (CI), 3.2–30.3] and cardiac arrest occurring during the second period (OR, 3.3; CI, 1.1–10.1). Conclusion: Prospective Utstein style data collection proved to be a valuable tool for the evaluation of management and outcome following in‐hospital cardiac arrest. Increased survival was seen over 10 years outside critical care areas. Organizational changes, including cardiopulmonary resuscitation training for ward personnel and standardized resuscitation management, may have contributed to this change. 相似文献
73.
Ville-Valtteri Välimäki Kirsi Piippo Stiina Välimäki Eliisa Löyttyniemi Kimmo Kontula Matti J. Välimäki 《Osteoporosis international》2005,16(12):1633-1640
The genes coding for estrogen receptor- (ER-) and androgen receptors (AR) are potential candidates for the regulation of bone mass and turnover, which may contribute to both the achievement of peak bone mass and bone loss after completion of growth. The present study was aimed at elucidating the role of two restriction fragment lengths (XbaI and PvuII) polymorphisms of the ER gene and the CAG repeat polymorphism of the AR gene as determinants of peak bone mass in men; special attention was paid to the interaction between serum free estradiol (E2) levels and the XbaI and PvuII genotypes. A cross-sectional study, with data on lifestyle factors collected retrospectively, was performed in 234 young men, aged 18.3 to 20.6 years. Of the men, 184 were recruits of the Finnish Army and 50 were men of similar age who had postponed their military service for reasons not related to health. Bone mineral content (BMC), density (BMD) and scan area were measured in the lumbar spine and upper femur by dual-energy X-ray absorptiometry (DXA). The bone turnover rate was assessed by measuring serum type I procollagen aminoterminal propeptide (PINP) and tartrate-resistant acid phosphatase 5b (TRACP5b) as well as urinary excretion of type I collagen aminoterminal telopeptide (NTX). After adjusting for age, height, weight, exercise, smoking, calcium and alcohol intake, BMC, scan area and BMD at all measurement sites were similar for the different XbaI and PvuII genotypes of the ER and independent of the number of the CAG repeats of the AR gene. No association was found between free E2 levels and bone parameters among any genotype group of the XbaI and PvuII polymorphisms. Except for urinary NTX, which showed a tendency to higher values for the xx ( P =0.08) and pp ( P =0.10) genotypes of the ER, bone turnover markers were not related to the genotypes studied. Our study does not support the view that the XbaI and PvuII polymorphisms of the ER gene and the CAG polymorphism of the AR gene would have a substantial impact on the development of peak bone mass in young Finnish men. 相似文献
74.
Madhi SA Kuwanda L Saarinen L Cutland C Mothupi R Käyhty H Klugman KP 《Vaccine》2005,23(48-49):5517-5525
The quantitative (anti-Hib capsular polysaccharide antibody concentrations; anti-HibPS) and qualitative (bactericidal activity and avidity) aspects in immune responses to Haemophilus influenzae type b polyribosyl ribitol phospshate-CRM(197) conjugate vaccine (HibCV; HibTiter) were evaluated in 66 HIV infected children not receiving anti-retroviral therapy and 127 HIV uninfected children. Surveillance was conducted for invasive Hib disease in a cohort of 39,865 (approximately 6.4% of whom were HIV infected) children from March 1998 to June 2004. HIV infected children had lower anti-HibPS geometric mean antibody concentrations 1 month post-immunisation than HIV uninfected children (P<0.00001) and were less likely to have anti-HibPS antibody concentrations of >or=1.0 microg/ml (RR 0.54; 95% CI 0.43-0.69). A lower proportion of HIV infected children than HIV uninfected children (RR 0.78; 95% CI 0.66-0.93) had measurable anti-Hib serum bactericidal activity (SBA) and the HibPS antibody concentration required for 50% killing of Hib bacteria was greater among HIV infected than HIV uninfected children (P=0.001). The estimated risk of HibCV failure was 35.1-fold greater (95% CI 14.6-84.6) amongst HIV infected than HIV uninfected children. 相似文献
75.
Randell J Saarinen A Walamies M Vahteristo M Silvasti M Lähelmä S 《Respiratory medicine》2005,99(12):307-1493
This randomised, double-blind, double-dummy, cumulative dose, multicentre crossover study aimed to demonstrate non-inferiority in safety of formoterol delivered via Easyhaler versus Aerolizer. The secondary objective was to compare the efficacy of the devices. Thirty-three adult asthmatic subjects entered the study and 32 completed it. The study comprised screening and two study days, with each subject inhaling 96 microg (12, 12, 24 and 48 microg) cumulative dose of formoterol via the study inhalers. Serum potassium (S-K+), vital signs and spirometry were performed at baseline, 1h after each dose and additionally 4h after the last dose. The primary safety variable was S-K+. Secondary safety variables were heart rate, corrected QT interval, blood pressure, serum glucose and adverse events. Spirometry was assessed to evaluate efficacy. The results showed non-inferiority in safety of formoterol inhaled via Easyhaler compared to Aerolizer. The adjusted treatment difference in the S-K+ values after 96 microg cumulative dose of formoterol was 0.14 mmol/L being clearly above the pre-determined lower limit of the non-inferiority criterion of -0.2 mmol/L. There were dose-related changes in secondary efficacy variables after both treatments. The changes were comparable in most of the parameters but heart rate was statistically significantly higher and decrease in diastolic blood pressure greater after formoterol via Aerolizer than that via Easyhaler. The occurrence of adverse events was dose-related, the most common events being tremor, hypokalaemia, headache and palpitation. The spirometry results showed no statistically significant difference in efficacy between the treatments. In conclusion, formoterol delivered via Easyhaler was as safe as via Aerolizer. 相似文献
76.
Laitinen K Arvola T Moilanen E Lampi AM Ruuska T Isolauri E 《Biology of the neonate》2005,87(1):66-72
OBJECTIVE: The aim of this study was to ascertain factors that might be protective of the appearance of gross blood in the stools of breast-fed infants. METHODS: Logistic regression models were formed to search for variables possibly explaining the condition. In addition to the analyzed breast milk factors, mother's allergic disease was introduced into the models to control for its possible confounding effect. The breast milk samples, collected from mothers of infants with gross blood in stools (n = 23) and from mothers of healthy age-matched infants (n = 71), were analyzed for concentrations of transforming growth factor-beta2, tumor necrosis factor-alpha, interleukin (IL)-4, IL-10, prostaglandin (PG)E2, cysteinyl leukotrienes (Cys-LTs) and fatty acid composition. RESULTS AND CONCLUSIONS: Increase in the concentrations of PGE2 and Cys-LTs in the breast milk together with mother's allergic disease reduced the likelihood of gross blood in stools in the breast-fed infant. The results suggest that no single factor, but a combination of immunomodulatory factors may protect the child from gross blood in the stools of breast-fed infants. Allergic disease was not a risk factor as mother's allergic disease appeared to counterbalance the gross blood in stools. Due to the preliminary nature of the study, the results need to be verified in a larger setting. The challenge for the future lies in identifying of such active compounds for dietary modification to enforce particularly the properties of the breast milk which are immunoprotective for the infant and to reduce the likelihood of intestinal disorders in at risk infants. 相似文献
77.
Isolauri E Ouwehand AC Laitinen K 《Acta paediatrica (Oslo, Norway : 1992). Supplement》2005,94(449):110-114
The increased prevalence of atopic diseases, i.e. atopic eczema, allergic rhinitis and asthma, has been described as the epidemic of the 21st century in Western societies. New approaches in the fight against allergic diseases are clearly called for, the target being the persistence of the allergic responder pattern beyond infancy. The advantage afforded by elimination diets lies in the silencing of specific allergic inflammation induced by an offending food. Novel nutritional approaches, beyond the treatment of food allergies, have recently attracted research interest subsequent to the identification of the immunomodulatory potential of specific dietary compounds. Dietary lipids as immunomodulators may prevent allergic sensitization by down-regulating inflammatory response whilst protecting the epithelial barrier. Probiotic bacteria have been shown to reinforce the different lines of gut defence: immune exclusion, immune elimination and immune regulation. On this basis, the strategy against allergic disease proposed here is based on the administration of tolerogenic gut-processed peptide fragments of a specific protein, in addition to the use of specific dietary compounds such as fatty acids and antioxidants, and introducing a microbial stimulus for the immature immune system by means of cultures of beneficial live micro-organisms characteristic of the healthy infant gut microbiota. 相似文献
78.
The present study evaluated the effect of galanthamine, a selective competitive cholinesterase inhibitor, on histological and functional outcome after experimental stroke in rats. Cholinesterase inhibitors are commonly used as cognitive enhancers for dementia in aged people, including those who may sustain ischemic attacks. Young adult (5 months) and aged (24 months) rats were treated with saline or galanthamine at a dose of 2.5 mg/kg (i.p., once a day). Drug treatment started 4 days before focal cortical photothrombosis (Rose Bengal, 20 mg/kg) and continued for 21 days thereafter. Sensorimotor recovery was assessed by a new beam-walking test and spatial learning by the Morris water-maze over a 3-week follow-up period. Infarct volumes were measured from nitroblue tetrazolium-stained sections at the end of follow-up. Infarct volumes in the cortex were similar in ischemic controls and ischemic rats treated with galanthamine. In the beam-walking test, there was a transient impairment forelimb function and a permanent impairment in hindlimb after cortical infarct both in young adult and aged rats. Galanthamine treatment did not affect the sensorimotor recovery rate. Analysis of water-maze data did not reveal significant differences in length of path, escape latency, or swim speed between sham-operated, ischemic controls and ischemic rats treated with galanthamine. In conclusion, present findings suggest that the aging brain has considerable plastic capacity to maintain functioning after focal cerebral insults restricted to the motor cortex. Galanthamine is not beneficial with respect to the histological or functional outcome in rats subjected to cortical photothrombosis. 相似文献
79.
80.
Hukki J Balan P Ceponiene R Kantola-Sorsa E Saarinen P Wikstrom H 《The Journal of craniofacial surgery》2004,15(2):185-191
The purpose of this article is to report the case of a 10-year-old girl born with anophthalmia, bilateral oblique facial clefts, and missing scalp and bones over the temporal and parietal areas of the cranial vault bilaterally. Early amnion rupture seems to be the most probable cause of this rare combination of anomalies. Because no similar case has been reported in the literature so far, we describe here the clinical and psychosocial history of this unusual patient, who has been able to live the intellectually and socially normal life of a blind child in spite of the major craniofacial deformities. The already completed and possible future therapeutic strategies are discussed. 相似文献